• Home
  • Academics
  • Student
  • Faculty
  • Community
  • Alumni
  • Community
  • Opportunities

The Pipette Gazette

0 Comment

Alum David Bearss in The News

12 Apr 2017

Alum David Bearss is now the chief executive officer of Lehi-based biotech firm Tolero Pharmaceuticals, whose team of scientists is conducting clinical trials on a drug that has shown promise in treating acute myeloid leukemia, or AML.

David Bearss is a PhD graduate of the Cellular & Structural Biology Graduate Program. He was in the lab of Jolene Windle and he graduated in 1999. He was also the CSB Graduate Program’s Distinguished Alumnus in 2012.

Photo Credit: Laura Seitz, Deseret news

Social Share

  • google-share

Filter by categories

  • Academics
  • All Blogs
  • Alumni
  • Alumni News
  • Beyond The Bench
  • Career Development
  • Career Series
  • Community
  • Faculty
  • Faculty News
  • Faculty Spotlight
  • Final Words…
  • In Press
  • Meet The Researcher
  • Opportunities & Upcoming Events
  • Student
  • Student News

Recent Posts

  • Final Words: Sonam Khurana & Her Passion For Oral and Maxillofacial Radiology
  • January Career Corner: Upcoming Events and Opportunities
  • Free 6 Week Bioinformatics Bootcamp Advanced Topics: Single Cell RNA-Seq
  • Long School of Medicine Research Week Scheduled For April 5-9
  • Gain Grant Writing Skills at F-Troop: Sessions Start Jan 20